Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
04/01/2010 | CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
04/01/2010 | CA2738794A1 Chromenone analogs as sirtuin modulators |
04/01/2010 | CA2738285A1 Method for producing lipids |
04/01/2010 | CA2738282A1 Method for concentrating lipids |
04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
04/01/2010 | CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
04/01/2010 | CA2736434A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
04/01/2010 | CA2735886A1 Indazole or 4,5,6,7-tetrahydro-indazole derivatives |
03/31/2010 | EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product |
03/31/2010 | EP2168992A1 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
03/31/2010 | EP2168982A1 GLP-1 analog fusion protein formulations |
03/31/2010 | EP2168965A1 Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists |
03/31/2010 | EP2168962A2 Phenylacetamides and their use as glucokinase modulators |
03/31/2010 | EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
03/31/2010 | EP2168950A1 Inhibitor of the differentiation of t cells into th1 cells |
03/31/2010 | EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
03/31/2010 | EP2168588A1 An extract of rehmannia glutinasa libosch. for reducing blood sugar, reducing blood fat, treating leukemia and preparation method and uses thereof |
03/31/2010 | EP2168587A1 A method for preparing a mixture containing natural vitamin p from hippophae rhamnoides l. |
03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
03/31/2010 | EP2167510A1 Sirtuin modulating imidazothiazole compounds |
03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
03/31/2010 | EP2167118A1 Transmembrane prostatic acid phosphatase |
03/31/2010 | EP2167075A1 Mixed lineage kinases and metabolic disorders |
03/31/2010 | EP2166883A2 Foodstuff composition to improve digestibility of foodstuff lipids |
03/31/2010 | EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
03/31/2010 | EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
03/31/2010 | CN101687961A Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
03/31/2010 | CN101687879A 5-furopyridinone substituted indazoles |
03/31/2010 | CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
03/31/2010 | CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer |
03/31/2010 | CN101687850A Substituted pyrimidines as adenosine receptor antagonists |
03/31/2010 | CN101687828A Thiadiazole derivatives as antidiabetic agents |
03/31/2010 | CN101687824A deuterated morpholinyl compounds |
03/31/2010 | CN101687810A Bicyclic compound and pharmaceutical use thereof |
03/31/2010 | CN101687800A glucokinase activator |
03/31/2010 | CN101687793A Crystal forms of saxagliptin and processes for preparing same |
03/31/2010 | CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
03/31/2010 | CN101687019A Medicaments and methods to treat autoimmune disease and cancer |
03/31/2010 | CN101686994A Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
03/31/2010 | CN101686988A pharmaceutical formulations containing dapagliflozin propylene glycol hydrate |
03/31/2010 | CN101686980A Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof |
03/31/2010 | CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
03/31/2010 | CN101686918A Slimming composition |
03/31/2010 | CN101686724A Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
03/31/2010 | CN101684158A Binding domain-immunoglobulin fusion proteins |
03/31/2010 | CN101684120A Riboflavin-5'-lauric acid monoester crystal form and preparation method thereof as well as medicine composite containing same |
03/31/2010 | CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
03/31/2010 | CN101684103A Compound with 1,2,4-triazole structure and preparation method and application thereof |
03/31/2010 | CN101684102A Phenoxyacetic acid ester pyrazine derivative as well as preparation method and applications thereof |
03/31/2010 | CN101684091A cannabinoid receptor ligands |
03/31/2010 | CN101684090A Method for preparing amorphous atorvastatin calcium |
03/31/2010 | CN101684089A bicycloester derivative |
03/31/2010 | CN101684088A Cyanomethyl pyrrole derivative and preparation method and application thereof |
03/31/2010 | CN101683531A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683530A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683529A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683467A Preparation method of tea for reducing blood fat |
03/31/2010 | CN101683464A Chinese medicinal composition for tonifying kidney and promoting blood circulation |
03/31/2010 | CN101683462A Traditional Chinese medicine composition for coursing the liver and tonifying kidney |
03/31/2010 | CN101683461A Application of a traditional Chinese medicine composition in preparation of medicament for inhibiting oxidation damage |
03/31/2010 | CN101683460A Method for preparing jadelike wine paste for promoting production of body fluid and quenching thirst |
03/31/2010 | CN101683454A Pure traditional Chinese medicine preparation |
03/31/2010 | CN101683453A Formula of traditional Chinese medicine preparation |
03/31/2010 | CN101683446A Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat |
03/31/2010 | CN101683367A Method for preparing emulsified medicinal composition containing oleum fructus bruceae |
03/31/2010 | CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof |
03/31/2010 | CN101683356A Water-soluble vitamin preparation for injection and preparation method thereof |
03/31/2010 | CN101683340A Sustained-release preparation of compound metformin hydrochloride rosiglitazone and preparation method thereof |
03/31/2010 | CN101683335A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683333A Method for preparing atorvastatin calcium adsorbate and relevant solvate thereof |
03/31/2010 | CN101683108A Ginger and honeysuckle composite flavor soft ice cream size and preparation method thereof |
03/31/2010 | CN100596273C One set of pure food composition for repairing pancreas function and curing type II diabetes, and food therapeutic producing method |
03/30/2010 | US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it |
03/30/2010 | US7687642 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
03/30/2010 | US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis |
03/30/2010 | US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors |
03/30/2010 | US7687620 [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents |
03/30/2010 | US7687514 Benzimidazole derivatives |
03/30/2010 | US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders |
03/30/2010 | US7687502 Substituted quinazoline or pyridopyrimidine derivative |
03/30/2010 | US7687492 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
03/30/2010 | US7687480 Phosphonate compounds |
03/30/2010 | US7687059 Systems and methods for treating patients with processed lipoaspirate cells |
03/30/2010 | US7687056 containing granulocyte colony-stimulating factor; diabetic nephropathy |
03/30/2010 | CA2544963C Myo-inositol hexaphosphate for topical use technical field |
03/30/2010 | CA2472237C Multi-stage oral drug controlled-release system |
03/30/2010 | CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
03/30/2010 | CA2442673C Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
03/30/2010 | CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
03/30/2010 | CA2418084C Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom |
03/30/2010 | CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
03/30/2010 | CA2355860C Dosage forms comprising porous particles |
03/30/2010 | CA2306429C Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
03/30/2010 | CA2229479C Method of promoting angiogenesis |
03/30/2010 | CA2208780C Antitumor and anticholesterol preparations comprising lipoteichoic acid lta-t of streptococcus sp dsm 8747 |
03/30/2010 | CA2171207C Methods for regulating gastrointestinal motility |
03/25/2010 | WO2010033981A2 5-azaindole bisphosphonates |
03/25/2010 | WO2010031820A1 Glucoside derivatives and uses thereof as sglt inhibitors |